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Abstract 
Central nervous system (CNS) development is driven by coordinated actions of 
developmental signals and chromatin regulators that precisely regulate gene expression 
patterns.  Histone methylation is a regulatory mechanism that controls transcriptional 
programs. In the last 10 years, several histone demethylases (HDM) were identified as 
important players in neural development, and their implication in cell fate decisions is 
beginning to be recognized. Identification of the physiological roles of these enzymes 
and their molecular mechanisms of action will be necessary for completely 
understanding the process that ultimately generates different neural cells in the CNS. In 
this review, we provide an overview of the Jumonji family of HDMs involved in 
neurodevelopment, and we discuss their roles during neural fate establishment and 
neuronal differentiation.  
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Introduction  
 The CNS is formed by different cell types that are generated during neural 
development. Neural progenitor cells (NPCs) proliferate to maintain their population, 
and at the same time, they differentiate, first to generate neurons, then oligodendrocytes 
and astrocytes (Guillemot, 2005). These complex processes occur in response to a 
variety of developmental cues, and their completion requires close coordination 
between transcription factors, extrinsic signals, and chromatin-modifying enzymes. The 
developmental signals and transcription factor families that control neurogenesis have 
been studied for many years, and they are quite well established (Lee and Pfaff, 2001, 
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Guillemot, 2007). However, recently, factors that interact with chromatin have emerged 
as regulators of neurogenesis and neural development. During the last decade, great 
efforts have been made to elucidate the role of epigenetic regulators that govern the 
transcriptional programs involved in neural development. 
 Eukaryotic DNA is organized into nucleosomes; this organization provides both 
a compact package of genetic material and a new layer of regulation for controlling its 
activity. Each nucleosome is composed of a DNA strand of 145-147 base pairs and two 
molecules each of histones H3, H4, H2A, and H2B. Moreover, the linker histone, H1, is 
required to compact the chromatin into high-order structures (Luger, 2003, Kouzarides, 
2007). The amino-terminal domains of H3, H4, H2A, and H2B undergo different types 
of post-translational modifications, mainly acetylation, methylation, phosphorylation, 
ubiquitination, and sumoylation (Kouzarides, 2007, Bannister and Kouzarides, 2011). 
These modifications evoke dynamic changes in the chromatin structure, which are 
essential for responding to both extrinsic and intrinsic signaling cues. In many cases, 
these responses lead to changes in gene expression that ultimately control 
transcriptional programs during development.  
 Although histone acetylation is the most studied and characterized histone 
modification (Kouzarides, 2007, Bannister and Kouzarides, 2011), in the last few years, 
many enzymes that catalyze the addition or removal of methyl groups from histones 
have been identified and widely studied. Methylation of histones can occur on lysine 
(K) and arginine (R) residues; in addition, K residues can undergo mono- (me1), di- 
(me2), or tri-methylation (me3), and R residues can undergo me1 and me2, positioned 
either symmetrically or asymmetrically. 
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 For many years, it was believed that histone methylation was an irreversible 
modification, and that the removal of methyl groups required a histone exchange. 
However, the finding that histone methylation patterns could respond to many signals in 
a reversible manner suggested that methylation/demethylation is a much more dynamic 
process than previously thought. The identification of the first histone demethylase 
(HDM) in 2004 (Shi, et al. 2004) confirmed this possibility. During the last decade, 
many HDMs have been identified (Table1). They were classified into two families: (i) 
the KDM1 family, whose members demethylate H3K4me2/1 and H3K9me2/1 in a 
flavin-adenine-dinucleotide dependent reaction (Shi, et al. 2004, Metzger, et al. 2005, 
Ciccone, et al. 2009); and (ii) the Jumonji (JMJC) family (Jumonji-c domain containing 
proteins), whose members utilize Fe(II) and 2-oxoglutarate in the demethylation 
reaction. The first JMJC HDM was identified in 2006 (Tsukada, et al. 2006). Since 
then, this family has greatly grown in number, and it includes enzymes that target me1, 
me2, and me3 histones [(Kooistra and Helin, 2012), Table 1].  
 Histone methylation is associated with both transcriptional activation 
(H3K4me3, H3K36me3, and H3K79me3/me2/me1) and repression (H3K9me3/me2, 
H4K20me3, and H3K27me3/me2). Interestingly, a combination of active and repressive 
histone methylations occurs in many promoters, and mainly in embryonic stem cells 
(ESCs). In particular, sites that carry H3K27me3 are often also enriched in H3K4me3. 
Sites marked by this combination of histone modifications with opposite regulatory 
potential are called bivalent domains, and they are thought to be responsible for 
maintaining genes in a poised state for activation (Azuara, et al. 2006, Bernstein, et al. 
2006). Accordingly, many chromatin-acting complexes contain both histone 
methyltransferases (HMT) and HDMs that catalyze functionally opposing 
modifications. For example, the one comprising MLL3-MLL4 H3K4me3 HMTs 
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combined with a H3K27me3 HDM, UTX (Agger, et al. 2007, Lee, et al. 2007b); 
another containing a H3K4me3 HDM, JARID1A (jumonji, AT-rich Interactive domain 
1A) together with polycomb responsive complex 2 (PRC2), which is responsible for 
H3K27me3 methylation (Pasini, et al. 2008). These close associations might facilitate 
coordinated chromatin modifications and ensure methylation balance is maintained for 
regulating proper development. Moreover, histone methylation occurs together with 
other histone modifications, mainly histone acetylation. Accordingly, HDMs are present 
in large protein complexes that often contain other histone-modifying enzymes; for 
example, the JARID1C H3K4me3/me2 HDM is associated with histone deacetylases 
(HDAC) HDAC1 and HDAC2, the HMT G9a, and the transcriptional repressor REST 
[(Tahiliani, et al. 2007), see below]. These associations facilitate coordinated 
interactions of different enzymes with multiple histone sites. Then, although a particular 
modification might correlate with either transcription activation or repression, the 
combination of histone modifications will determine the final biological output (de la 
Cruz, et al. 2005, Taverna, et al. 2007, Lois, et al. 2010). 
 During the last few years, it was proposed that HDMs played a central role in 
development, particularly in a neural context, and in diseases (Lee and Lee, 2010, 
Pedersen and Helin, 2010,  Pattaroni and Jacob, 2013) (Table 2). However, we are just 
beginning to understand the molecular mechanisms through which HDMs cooperate 
with signals, to coordinate neural development. In this review, we briefly summarize the 
roles of Jumonji family members in different aspects of neurogenesis. In addition, we 
will highlight the major questions that remain open for future investigation. 
 
Function of Jumonji demethylases in neural development 
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 The first identified protein containing Jumonji-c domain was JARID2 that 
interestingly lacks the histone demethylase activity. However, it is essential for normal 
embryonic development and in particular for neural development  (Landeira and Fisher, 
2011). JARID2 associates with PRC2 to facilitate the latter's recruitment to target genes 
(Peng, et al., 2009, Shen, et al., 2009, Pasini, et al., 2010). As PRC complexes are 
required at different steps of neurogenesis, JARID2 might contribute to neural 
development by regulating PRC recruitment. The rest of proteins with a Jumonji-c 
domain are catalytically active and they are classified into subfamilies (HDM2/7). Each 
one contains different enzymes that target a particular lysine/s mainly on histones H3 
and H4. They are highly specific for both K residues and degree of methylation (Table 
1). Recently, many reports highlight the importance of the equilibrium between HMT 
and HDM enzymatic activities in the control of the final state of histone methylation 
during neural development. This is a key determinant of both neural commitment in 
ESCs and cell fate determination in NSCs. In accordance with that notion, many reports 
have proposed an essential role of PRC2 during neural development. PRC2 occupies 
and represses many neural-developmental regulators in ESCs (Boyer, et al. 2006, 
Bracken, et al. 2006, Lee, et al. 2006); moreover, H3K27me3 levels decrease in many 
neural-specific genes during neural differentiation (Boyer, et al. 2006, Burgold, et al. 
2008). PRC complexes are also required for NPCs differentiation. High levels of 
Enhancer of Zeste Homologue 2 (EZH2), the enzyme in PRC2 that methylates 
H3K27me3/me2, are required for NPC differentiation to oligodendrocytes. Conversely, 
Ezh2 expression decreases to allow neuronal and astrocytic differentiation (Sher, et al., 
2008). Finally, during the neurogenic to astrogenic transition, PRC proteins suppress 
neurogenic competence of NPCs by inhibiting Neurog1 expression. At the late stage of 
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NPCs, histone acetylation of the Neurog1 promoter decreases and H3K27me3 increases 
leading to repression of Neurog1 (Hirabayashi, et al., 2009).  
 Another good example remarking the importance of the balance between the 
histone methylation and demethylation is the regulation of the GFAP promoter during 
differentiation of NPCs into astrocytes. At this stage of development, FGF2 induces the 
decrease of H3K9me3 and the increase of H3K4me3 levels on the GFAP promoter 
leading to the activation of this astrocyte-specific marker (Song and Ghosh, 2004).  
 In this review we will discuss the function of the different HDMs controlling the 
histone methylation levels during neural development. Among them, we will mainly 
focus on those targeting H3K4 and H3K27 sites, because they have been associated 
with the major neural phenotypes.  
 
KDM5 Subfamily 
 The KDM5 subfamily members catalyze the demethylation of H3K4me3/me2 
(Christensen, et al. 2007, Iwase, et al. 2007, Klose, et al. 2007, Lee, et al. 2007a, 
Tahiliani, et al. 2007, Yamane, et al. 2007). The mammalian family comprises the 
JARID1A-D proteins (Table 1). These enzymes, particularly JARID1B and C, are 
involved in different aspects of neural development.  
 Recent work with Jarid1B knockout mouse embryos revealed that this HDM 
performs essential functions in neural development. Deletion of Jarid1B led to several 
neural defects, including disorganized cranial nerves, defects in eye development, and 
an increased incidence of exencephaly (Albert, et al. 2013). JARID1B binds to neural 
master regulator genes such as Pax6 and Otx2, to maintain low levels of H3K4me3. In 
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Jarid1B KO embryos, increased levels of H3K4me3 were associated with both 
repressed and bivalent genes, which made these genes more susceptible to activation 
(Albert, et al. 2013) (Fig. 1). Furthermore, ESCs require JARID1B activity for proper 
differentiation into neurons (Schmitz, et al. 2011). On the other hand, Jarid1B over-
expression in ESCs decreased the expression of other genes that regulate cell fate 
decisions, like Egr1, p27, and BMI1. These findings demonstrated that JARID1B plays 
an important role in balancing proliferation and differentiation during development 
(Dey, et al. 2008). 
 The best-known member of the KDM5 subfamily is JARID1C. JARID1C is 
strongly related to X-linked mental retardation (XLMR) and epilepsy (Jensen, et al. 
2005, Tzschach, et al. 2006, Tahiliani, et al. 2007, Jensen, et al. 2010). The mutations 
found in patients with XLMR frequently compromise JARID1C HDM activity (Iwase, 
et al. 2007, Tahiliani, et al. 2007). Shi's group has shown that, in combination with 
REST, G9a, and HDAC1/2, JARID1C repressed a subset of the REST target genes by 
binding to the neuron-restrictive silencing elements in their promoters. Thus, the 
JARID1C/REST complex maintains the neuronal genes silenced in non-neuronal cells. 
Additionally, when Jarid1C was knocked down in primary rat cerebellar granule 
neurons, dendritic morphogenesis was impaired. Moreover, studies in zebrafish 
demonstrated that Jarid1C plays a role in brain-patterning establishment and neuronal 
survival (Iwase, et al. 2007). 
 Taken together, the published data indicate that the JARID1 family is critical for 
normal neural development. Its major role is to fine-tune the expression of important 
neural regulators by maintaining appropriate H3K4me3 levels to ensure a balance 
between active and repressive histone modifications. An alteration in this balance can 
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affect phenotypical outcome when the developmental transcription potential takes 
advantage of that. 
 
The KDM6 subfamily 
KDM6 subfamily members catalyze H3K27me3/me2 demethylation. This 
family includes UTX, JMJD3, and UTY proteins, although HDM activity has not been 
shown for UTY (Agger, et al. 2007, De Santa, et al. 2007, Lan, et al. 2007, Lee, et al. 
2007b).  
 As described above, the H3K27 methylation status is essential for cell fate 
determination in stem cells.  Accordingly, H3K27me3/me2 HDMs are involved in 
important aspects of neural development. Several studies have demonstrated that 
JMJD3 (unlike UTX) is highly regulated at the transcriptional level in response to 
different developmental, differentiation, and stress-related signals. In a developmental 
context, Jmjd3 was up-regulated during differentiation of ESCs to a neural lineage, and 
it was required for neuronal commitment (Burgold, et al. 2008). Besides, over-
expression of Jmjd3 in NPCs induced the expression of various neuronal genes in a 
HDM activity-dependent manner (Jepsen, et al., 2007). Moreover, it has been described 
a direct relation between JMJD3 and the corepressor SMRT (silencing mediator of 
retinoic acid and thyroid hormone receptor) that is essential for proper forebrain 
development. SMRT is necessary to maintain the NSC state, mediating the retinoic-
acid- and Notch-dependent transcriptional response. In isolated NPCs, SMRT prevented 
retinoic-acid-receptor-dependent induction of neuronal differentiation in the absence of 
any ligand by repressing Jmjd3, which in turn participates in the activation of the 
neurogenic program (Fig. 2). Mechanistically, JMJD3 has been shown to cooperate with 
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a number of different signals during neural development. (i) In P19 cells, in response to 
retinoic acid (RA), JMJD3 was recruited by the Hes1 transcription factor to the Mash1 
promoter to facilitate efficient expression of the Mash1 gene and to drive RA-induced 
neuronal differentiation (Dai, et al. 2010). (ii) In vivo experiments in the chick neural 
tube have demonstrated that TGFβ-induced neuronal differentiation was dependent on 
JMJD3 HDM activity (Estarás, et al. 2012). Moreover, in neural stem cells (NSCs), 
upon signaling activation, SMAD3 recruited JMJD3 to the promoter of TGFβ-
responsive genes to facilitate transcription elongation, which allowed the TGFβ 
developmental program to proceed (Estarás, et al. 2012, Estarás, et al. 2013) (Fig. 3). 
(iii) In response to BMP pathway activation, JMJD3 interacted with SMAD1/SMAD4 
to demethylate and activate the NOGGIN promoter during spinal cord development. At 
the same time, NOGGIN antagonized the BMP pathway, generating a negative-
feedback regulatory loop, which controlled the dorsal interneuron generation mediated 
by JMJD3 HDM activity (Akizu, et al. 2010). These data point to JMJD3 as a critical 
integrator of neural developmental cues. Accordingly, a knockout of the mouse Jmjd3 
caused perinatal lethality due to an immature respiratory neuronal network (Burgold, et 
al. 2012). Furthermore, JMJD3 was shown to be essential for M2 microglia 
polarization. Suppressing Jmjd3 in N9 microglia led to the inhibition of M2 
polarization, an increase in M1 microglial inflammatory responses, and induction of 
neuronal death in vitro (Tang, et al. 2014).  
 These data suggested that JMJD3 is the member of the KDM6 subfamily that 
plays a central role in regulating H3K27me3/me2 levels in neural genes. Nevertheless, 
UTX has also been reported to play a functional role in neural development. 
Incorporation of UTX, but not JMJD3, into the HOX gene regions was required for RA-
induced neural differentiation in hESCs (Shahhoseini, et al. 2013). 
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Several reports have suggested that non-histone proteins can also be targeted and 
regulated by both HMT and HDM enzymes (Huang, et al. 2007). Recent data have 
indicated that JMJC-mediated demethylation of non-histone substrates might contribute 
to neural differentiation. The interaction between JMJD3 and p53 during mouse NSC 
differentiation resulted in nuclear accumulation of p53 (Sola, et al. 2011). Another 
member of the p53 family, p63 (TAp63g), is a direct target of JMJD3 HDM activity. 
Through demethylation, JMJD3 stabilizes p63 and influences its cellular distribution to 
promote the correct expression of p63-regulated neural-specific genes (Fonseca, et al. 
2012). 
 
The KDM7 subfamily 
The KDM7 subfamily, also called PHF (plant homeodomain finger), is the most 
recently identified HDM subfamily.  In mammals, it consists of three proteins: 
KIAA1718 which targets H3K9me2/me1 and H3K27me2/1 (Horton, et al. 2010, 
Huang, et al. 2010b, Tsukada, et al. 2010); PHF8, which demethylates H3K9me2/me1 
and H4K20me1 (Horton, et al. 2010, Liu, et al. 2010, Loenarz, et al. 2010, Qi, et al. 
2010); and PHF2, which targets H3K9me2/me1 and H4K20me3 (Wen, et al. 2010, 
Baba, et al. 2011, Stender, et al. 2012, ). 
PHF8 is the best-known member of the subfamily, partly because PHF8 
mutations have been found in patients with XLMR or cleft lip/palate (Laumonnier, et al. 
2005, Abidi, et al. 2007, Koivisto, et al. 2007). Interestingly, many of these mutations 
impair the HDM catalytic activity (Loenarz, et al. 2010, Qiu, et al. 2010, Yu, et al. 
2010). How mutations on PHF8 lead to XLMR remains unclear. Many studies have 
implicated PHF8 in the regulation of XLMR-related genes, including JARID1C (see 
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above). Moreover, PHF8 associates with a zinc finger protein that is related to XLMR, 
ZNF11 (Kleine-Kohlbrecher, et al. 2010). Recent data demonstrated that PHF8 HDM 
activity was essential for promoting cytoskeleton dynamics, and it was required for 
proper neurite outgrowth in mouse primary cortical neurons (Asensio-Juan, et al. 2012). 
Consistent with those findings, depletion of the zebrafish PHF homolog led to a 
decrease in tectum size, a loss of neurons, and craniofacial alterations (Qi, et al. 2010, 
Tsukada, et al. 2010). Although PHF8 is the most studied member of the KDM7 
subfamily, another HDM of this subfamily has been associated with neural 
development. When KIAA1718 was knocked down, neural differentiation was blocked 
in mouse ESCs. This proneural effect was due to the direct transcriptional activation of 
FGF4, a signaling component implicated in neural differentiation (Huang, et al. 2010b). 
In addition, KIAA1718 promoted neural induction in early chick embryos; its over-
expression led to an expansion of the neural plate (Huang, et al. 2010a). 
 
The HDM2/3/4 subfamilies 
 Although not so many data support a definite role for the KDM2, KDM3, or 
KDM4 subfamilies in neural development, we will point to some studies that reveal 
their importance in such a context. JMJD1C, a member of the KDM3 subfamily, that 
targets H3K9me2/me1 (Yamane, et al. 2006, Kim, et al. 2010, Kim, et al. 2012), has 
been recently shown to repress neural differentiation. JMJD1C binds and demethylates 
miR-302 promoter to induce miR-302 expression, which prevents neural induction 
(Wang, et al. 2014). The mammalian KDM4A subfamily includes four members: 
KDM4A (Klose, et al. 2006, Whetstine, et al. 2006, Trojer, et al. 2009), KDM4B 
(Fodor, et al. 2006, Whetstine, et al. 2006, Trojer, et al. 2009), KDM4C (Cloos, et al. 
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2006, Whetstine, et al. 2006, Trojer, et al. 2009) and KDM4D (Whetstine, et al. 2006, 
Shin and Janknecht, 2007, Trojer, et al. 2009). Interestingly, it was recently shown that 
KDM4A drives neural crest specification in the chick embryo; loss of KDM4 leads to a 
down-regulation of neural crest specifier genes due to demethylation of regulatory 
regions (Strobl-Mazzulla, et al. 2010). The KDM2 subfamily, which targets 
H3K36me2/me1 (Tsukada, et al. 2006, He, et al. 2008, Lagarou, et al. 2008) and 
H3K4me3 (Frescas, et al. 2007) was reported to be involved mainly in oncogenesis 
(Suzuki, et al. 2006, Pfau, et al. 2008).  
 
Role of jumonji family in neurodevelopmental diseases 
As described in the Introduction, histone methylation/demethylation equilibrium 
plays an essential role in development, particularly during neural development. Thus, it 
is not surprising that specific alterations in HMT and HDM activities correlate with 
neurodevelopmental disorders (Table 2). For example, changes in HDM activity, due to 
mutations in JARID1C and PHF8, have been linked to mental retardation and facial 
morphological alterations in humans. A close analysis of the Jarid1C expression pattern 
in mice indicated that it was highly expressed in the hippocampus, which points to a 
role in cognition. Moreover, studies performed in different animal models have 
demonstrated that JARID1C is involved in neuronal survival and dendritic development 
(Iwase, et al. 2007). Similarly, PHF8 HDM activity is required for neurite outgrowth 
(Asensio-Juan, et al. 2012). Thus, the XLMR associated with PHF8 mutations might be 
due to deficient neuronal network establishment during development. Interestingly, the 
genes that encode JARID1C and PHF8 are located on the X chromosome, where the 
genes that regulate cognitive functions are more represented than in autosomes 
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(Pattaroni and Jacob, 2013). Taken together, these data provide new insights into 
XLMR in humans, and they hint that HDM activity plays a critical role.  
Other developmental diseases that have been directly or indirectly related to 
alterations in HDM activity include: (i) the Kabuki syndrome, which causes 
developmental delay and congenital anomalies; it has been recently associated with a 
deletion of the UTX gene (Lederer, et al. 2012); (ii) autism spectrum disorders (ASD) 
have been related with alterations in the activity of at least two HDMs: JARID1C 
(Adegbola, et al. 2008) and JMJD2C (Kantojarvi, et al. 2010). 
Finally, several reports have suggested that JMJD3, UTX, and KDM2B HDMs 
might play critical roles in cranial neural tube development (Cox, et al. 2010, Fukuda, et 
al. 2011, Tsurubuchi, et al. 2013). For example, Kdm2B-deficient mice exhibited failure 
of neural tube closure, which led to exencephaly (Fukuda, et al. 2011). In addition, 
decreased levels of JMJD3 were found in the amniotic fluid and serum of pregnant 
women with neural tube defect-affected embryos (Tsurubuchi, et al. 2013). These data 
have opened the possibility that these HDMs, or their enzymatic activities, may serve as 
potential therapeutic targets and as biomarkers for associated conditions. 
 
Conclusions and future perspectives 
 During neural development, a complex regulatory network controls 
transcriptional programs. In the last decade, HDMs have been identified as key 
components of this network (Fig. 4). In addition to methylation, other modifications on 
histones can fine-tune transcriptional activity at each developmental stage. 
Consequently, many HDMs and HMTs are found in multiprotein complexes that 
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contain other histone-modifying activities that coordinate the establishment of the final 
epigenetic landscape.  
 Although enormous progress has been made in the last few years in 
understanding the regulatory mechanisms that control the activity of HDMs, many 
questions remain open. It is particularly important to clarify how HDMs find their 
appropriate target genes in each different developmental context. HDMs act in 
coordination with intrinsic transcriptional programs and extrinsic signals. Thus, we 
speculate that direct interactions with transcription factors and the responses to 
developmental signals will determine how HDMs are recruited to specific sets of genes 
to provide a time- and space-appropriate response. How extrinsic signals control HDM 
activity remains an unanswered question. Developmental cues might affect their 
association with other histone-modifying enzymes, with transcription factors, or with 
other cellular components. In addition, extrinsic signals may directly modify the HDMs 
to alter their enzymatic activity, their stability, or their cellular localization.  
 Another unresolved question is: what is the cellular role of HDMs? Many data in 
the literature indicate that, although they contribute to transcriptional control, they do 
not play an instructive role during gene transcription; instead, they modulate the 
response to fine-tune the transcriptional output. The importance of non-histone substrate 
demethylation could also be relevant in HDM modulation of transcription. Moreover, 
many studies have confirmed that several HDMs play a role that is independent of 
HDM activity (Koyama-Nasu, et al. 2007, Secombe, et al. 2007, Lagarou, et al. 2008, 
Li, et al. 2008, Lee, et al. 2009, Miller, et al. 2010, DiTacchio, et al. 2011, Landeira and 
Fisher, 2011, Shpargel, et al. 2012). Experiments that address the role of HDM activity 
are essential for fully understanding the contribution of these enzymes to cellular 
responses.  
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 To comprehend the role of HDMs, it will be important to characterize dynamic 
changes in genome-wide histone modification patterns and changes in their specific 
targets during development. Finally, the generation of more animal models to analyze in 
vivo functions at different developmental stages will be crucial for understanding the 
role of these enzymes in neural development and in neurodevelopmental diseases. 
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Figure Legends 
Fig. 1 Function of JARID1B in mouse neural development. a JARID1B maintains the 
low levels of H3K4me3 that are needed to repress key neural development genes, such 
as Pax6 and Otx2. b In Jarid1b KO embryos, H3K4me3 levels are increased, and a high 
neonatal lethality is observed together with several neurodevelopmental defects (Albert 
et al. 2013). Red arrows mean gene silencing, green arrows depict transcription 
activation 
  
Fig. 2 SMRT repression of retinoic acid-dependent JMJD3 expression avoids neuronal 
differentiation. a SMRT blocks the expression of JMJD3 by counteracting its retinoic 
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acid-dependent activation. As a consequence, H3K27me3 at Dlx5 promoter is not 
removed, the gene remains silent, and the NSC state is maintained. b In SMRT KO 
mice retinoic acid receptor (RAR) binds to the retinoic acid responsive element (RARE) 
and promotes Jmjd3 transcription activation. Demethylation by JMJD3 causes Dlx5 
gene induction and NSC differentiation into neurons (Jepsen et al. 2007). Red arrows 
mean gene silencing, green arrows depict transcription activation  
Fig. 3 JMJD3 cooperates with TGFβ signaling to induce expression of the neurogenic 
gene Neurog2. a In the absence of the signal, Neurog2 remains silent due to the high 
levels of H3K27me3 on its promoter and coding region. b Upon TGFβ stimulation 
SMAD3 is recruited to the Neurog2 promoter and targets JMJD3 to this region. c 
JMJD3 interacts with RNA polymerase II phosphorylated in serine 2 and promotes 
transcription elongation by demethylating the gene body (Estaras et al. 2012, Estaras et 
al. 2013). Red arrows mean gene silencing, green arrows depict transcription activation 
(small arrowhead: initiation, big arrowhead: high expression) 
Fig. 4 JMJC histone demethylases are essential for progression from ESCs to terminal 
differentiated neurons. In ESCs, JMJD1C is necessary to maintain the stem cell state, 
while JARID1C, UTX, JMJD3 and KIAA1718 are required to promote neural 
commitment and differentiation from ESCs to NSCs. In addition, JMJD3 is 
fundamental to induce neurodifferentiation from NSCs, collaborating with RA, 
TGFβ and BMP pathways. Finally, the HDMs JARID1C and PHF8 contribute to the 
correct development and maintenance of axons and dendrites in mature neurons 
 
References 
                                                                                                                                      Fueyo et al. 
18  
Abidi FE, Miano MG, Murray JC, Schwartz CE (2007) A novel mutation in the PHF8 
gene is associated with X-linked mental retardation with cleft lip/cleft palate. 
Clin Genet 72:19-22 
Adegbola A, Gao H, Sommer S, Browning M (2008) A novel mutation in 
JARID1C/SMCX in a patient with autism spectrum disorder (ASD). Am J Med 
Genet A 146A:505-511 
Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J, Issaeva I, Canaani E, 
Salcini AE, Helin K (2007) UTX and JMJD3 are histone H3K27 demethylases 
involved in HOX gene regulation and development. Nature 449:731-734 
Akizu N, Estaras C, Guerrero L, Marti E, Martinez-Balbas MA (2010) H3K27me3 
regulates BMP activity in developing spinal cord. Development 137:2915-2925 
Albert M, Schmitz SU, Kooistra SM, Malatesta M, Morales Torres C, Rekling JC, 
Johansen JV, Abarrategui I, Helin K (2013) The histone demethylase Jarid1b 
ensures faithful mouse development by protecting developmental genes from 
aberrant H3K4me3. PLoS Genet 9:e1003461 
Asensio-Juan E, Gallego C, Martinez-Balbas MA (2012) The histone demethylase 
PHF8 is essential for cytoskeleton dynamics. Nucleic Acids Res 40:9429-9440 
Azuara V, Perry P, Sauer S, Spivakov M, Jorgensen HF, John RM, Gouti M, Casanova 
M, Warnes G, Merkenschlager M, Fisher AG (2006) Chromatin signatures of 
pluripotent cell lines. Nat Cell Biol 8:532-538 
Baba A, Ohtake F, Okuno Y, Yokota K, Okada M, Imai Y, Ni M, Meyer CA, Igarashi 
K, Kanno J, Brown M, Kato S (2011) PKA-dependent regulation of the histone 
lysine demethylase complex PHF2-ARID5B. Nat Cell Biol 13:668-675 
Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. 
Cell Res 21:381-395 
Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, 
Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES 
(2006) A bivalent chromatin structure marks key developmental genes in 
embryonic stem cells. Cell 125:315-326 
Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, 
Wernig M, Tajonar A, Ray MK, Bell GW, Otte AP, Vidal M, Gifford DK, 
Young RA, Jaenisch R (2006) Polycomb complexes repress developmental 
regulators in murine embryonic stem cells. Nature 441:349-353 
Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K (2006) Genome-wide mapping 
of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 
20:1123-1136 
Burgold T, Spreafico F, De Santa F, Totaro MG, Prosperini E, Natoli G, Testa G (2008) 
The histone H3 lysine 27-specific demethylase Jmjd3 is required for neural 
commitment. PLoS One 3:e3034 
Burgold T, Voituron N, Caganova M, Tripathi PP, Menuet C, Tusi BK, Spreafico F, 
Bevengut M, Gestreau C, Buontempo S, Simeone A, Kruidenier L, Natoli G, 
Casola S, Hilaire G, Testa G (2012) The H3K27 demethylase JMJD3 is required 
for maintenance of the embryonic respiratory neuronal network, neonatal 
breathing, and survival. Cell Rep 2:1244-1258 
Christensen J, Agger K, Cloos PA, Pasini D, Rose S, Sennels L, Rappsilber J, Hansen 
KH, Salcini AE, Helin K (2007) RBP2 belongs to a family of demethylases, 
specific for tri-and dimethylated lysine 4 on histone 3. Cell 128:1063-1076 
Ciccone DN, Su H, Hevi S, Gay F, Lei H, Bajko J, Xu G, Li E, Chen T (2009) KDM1B 
is a histone H3K4 demethylase required to establish maternal genomic imprints. 
Nature 461:415-418 
                                                                                                                                      Fueyo et al. 
19  
Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, Antal T, Hansen KH, 
Helin K (2006) The putative oncogene GASC1 demethylates tri- and 
dimethylated lysine 9 on histone H3. Nature 442:307-311 
Cox BJ, Vollmer M, Tamplin O, Lu M, Biechele S, Gertsenstein M, van Campenhout 
C, Floss T, Kuhn R, Wurst W, Lickert H, Rossant J (2010) Phenotypic 
annotation of the mouse X chromosome. Genome Res 20:1154-1164 
Dai JP, Lu JY, Zhang Y, Shen YF (2010) Jmjd3 activates Mash1 gene in RA-induced 
neuronal differentiation of P19 cells. J Cell Biochem 110:1457-1463 
de la Cruz X, Lois S, Sanchez-Molina S, Martinez-Balbas MA (2005) Do protein motifs 
read the histone code? Bioessays 27:164-175 
De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G (2007) The 
histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of 
polycomb-mediated gene silencing. Cell 130:1083-1094 
Dey BK, Stalker L, Schnerch A, Bhatia M, Taylor-Papidimitriou J, Wynder C (2008) 
The histone demethylase KDM5b/JARID1b plays a role in cell fate decisions by 
blocking terminal differentiation. Mol Cell Biol 28:5312-5327 
DiTacchio L, Le HD, Vollmers C, Hatori M, Witcher M, Secombe J, Panda S (2011) 
Histone lysine demethylase JARID1a activates CLOCK-BMAL1 and influences 
the circadian clock. Science 333:1881-1885 
Estaras C, Akizu N, Garcia A, Beltran S, de la Cruz X, Martinez-Balbas MA (2012) 
Genome-wide analysis reveals that Smad3 and JMJD3 HDM co-activate the 
neural developmental program. Development 139:2681-2691 
Estaras C, Fueyo R, Akizu N, Beltran S, Martinez-Balbas MA (2013) RNA polymerase 
II progression through H3K27me3-enriched gene bodies requires JMJD3 histone 
demethylase. Mol Biol Cell 24:351-360 
Fodor BD, Kubicek S, Yonezawa M, O'Sullivan RJ, Sengupta R, Perez-Burgos L, 
Opravil S, Mechtler K, Schotta G, Jenuwein T (2006) Jmjd2b antagonizes H3K9 
trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev 
20:1557-1562 
Fonseca MB, Nunes AF, Morgado AL, Sola S, Rodrigues CM (2012) TAp63gamma 
demethylation regulates protein stability and cellular distribution during neural 
stem cell differentiation. PLoS One 7:e52417 
Frescas D, Guardavaccaro D, Bassermann F, Koyama-Nasu R, Pagano M (2007) 
JHDM1B/FBXL10 is a nucleolar protein that represses transcription of 
ribosomal RNA genes. Nature 450:309-313 
Fukuda T, Tokunaga A, Sakamoto R, Yoshida N (2011) Fbxl10/Kdm2b deficiency 
accelerates neural progenitor cell death and leads to exencephaly. Mol Cell 
Neurosci 46:614-624 
Guillemot F (2005) Cellular and molecular control of neurogenesis in the mammalian 
telencephalon. Curr Opin Cell Biol 17:639-647 
Guillemot F (2007) Cell fate specification in the mammalian telencephalon. Prog 
Neurobiol 83:37-52 
He J, Kallin EM, Tsukada Y, Zhang Y (2008) The H3K36 demethylase Jhdm1b/Kdm2b 
regulates cell proliferation and senescence through p15(Ink4b). Nat Struct Mol 
Biol 15:1169-1175 
Hirabayashi Y, Suzki N, Tsuboi M, Endo TA, Toyoda T, Shinga J, Koseki H, Vidal M, 
Gotoh Y (2009) Polycomb limits the neurogenic competence of neural precursor 
cells to promote astrogenic fate transition. Neuron 63:600-613 
                                                                                                                                      Fueyo et al. 
20  
Horton JR, Upadhyay AK, Qi HH, Zhang X, Shi Y, Cheng X (2010) Enzymatic and 
structural insights for substrate specificity of a family of jumonji histone lysine 
demethylases. Nat Struct Mol Biol 17:38-43 
Huang C, Chen J, Zhang T, Zhu Q, Xiang Y, Chen CD, Jing N (2010a) The dual histone 
demethylase KDM7A promotes neural induction in early chick embryos. Dev 
Dyn 239:3350-3357 
Huang C, Xiang Y, Wang Y, Li X, Xu L, Zhu Z, Zhang T, Zhu Q, Zhang K, Jing N, 
Chen CD (2010b) Dual-specificity histone demethylase KIAA1718 (KDM7A) 
regulates neural differentiation through FGF4. Cell Res 20:154-165 
Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M, Opravil S, 
Shiekhattar R, Bedford MT, Jenuwein T, Berger SL (2007) p53 is regulated by 
the lysine demethylase LSD1. Nature 449:105-108 
Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, Qi HH, Whetstine JR, Bonni 
A, Roberts TM, Shi Y (2007) The X-linked mental retardation gene 
SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 
128:1077-1088 
Jensen LR, Amende M, Gurok U, Moser B, Gimmel V, Tzschach A, Janecke AR, 
Tariverdian G, Chelly J, Fryns JP, Van Esch H, Kleefstra T, Hamel B, Moraine 
C, Gecz J, Turner G, Reinhardt R, Kalscheuer VM, Ropers HH, Lenzner S 
(2005) Mutations in the JARID1C gene, which is involved in transcriptional 
regulation and chromatin remodeling, cause X-linked mental retardation. Am J 
Hum Genet 76:227-236 
Jensen LR, Bartenschlager H, Rujirabanjerd S, Tzschach A, Numann A, Janecke AR, 
Sporle R, Stricker S, Raynaud M, Nelson J, Hackett A, Fryns JP, Chelly J, de 
Brouwer AP, Hamel B, Gecz J, Ropers HH, Kuss AW (2010) A distinctive gene 
expression fingerprint in mentally retarded male patients reflects disease-causing 
defects in the histone demethylase KDM5C. Pathogenetics 3:2 
Jepsen K, Solum D, Zhou T, McEvilly RJ, Kim HJ, Glass CK, Hermanson O, 
Rosenfeld MG (2007) SMRT-mediated repression of an H3K27 demethylase in 
progression from neural stem cell to neuron. Nature 450:415-419 
Kantojarvi K, Onkamo P, Vanhala R, Alen R, Hedman M, Sajantila A, Nieminen-von 
Wendt T, Jarvela I (2010) Analysis of 9p24 and 11p12-13 regions in autism 
spectrum disorders: rs1340513 in the JMJD2C gene is associated with ASDs in 
Finnish sample. Psychiatr Genet 20:102-108 
Kim JY, Kim KB, Eom GH, Choe N, Kee HJ, Son HJ, Oh ST, Kim DW, Pak JH, Baek 
HJ, Kook H, Hahn Y, Chakravarti D, Seo SB (2012) KDM3B is the H3K9 
demethylase involved in transcriptional activation of lmo2 in leukemia. Mol 
Cell Biol 32:2917-2933 
Kim SM, Kim JY, Choe NW, Cho IH, Kim JR, Kim DW, Seol JE, Lee SE, Kook H, 
Nam KI, Bhak YY, Seo SB (2010) Regulation of mouse steroidogenesis by 
WHISTLE and JMJD1C through histone methylation balance. Nucleic Acids 
Res 38:6389-6403 
Kleine-Kohlbrecher D, Christensen J, Vandamme J, Abarrategui I, Bak M, Tommerup 
N, Shi X, Gozani O, Rappsilber J, Salcini AE, Helin K (2010) A functional link 
between the histone demethylase PHF8 and the transcription factor ZNF711 in 
X-linked mental retardation. Mol Cell 38:165-178 
Klose RJ, Yamane K, Bae Y, Zhang D, Erdjument-Bromage H, Tempst P, Wong J, 
Zhang Y (2006) The transcriptional repressor JHDM3A demethylates trimethyl 
histone H3 lysine 9 and lysine 36. Nature 442:312-316 
                                                                                                                                      Fueyo et al. 
21  
Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, Tempst P, Gilliland 
DG, Zhang Y, Kaelin WG, Jr. (2007) The retinoblastoma binding protein RBP2 
is an H3K4 demethylase. Cell 128:889-900 
Koivisto AM, Ala-Mello S, Lemmela S, Komu HA, Rautio J, Jarvela I (2007) 
Screening of mutations in the PHF8 gene and identification of a novel mutation 
in a Finnish family with XLMR and cleft lip/cleft palate. Clin Genet 72:145-149 
Kooistra SM, Helin K (2012) Molecular mechanisms and potential functions of histone 
demethylases. Nat Rev Mol Cell Biol 13:297-311 
Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693-705 
Koyama-Nasu R, David G, Tanese N (2007) The F-box protein Fbl10 is a novel 
transcriptional repressor of c-Jun. Nat Cell Biol 9:1074-1080 
Lagarou A, Mohd-Sarip A, Moshkin YM, Chalkley GE, Bezstarosti K, Demmers JA, 
Verrijzer CP (2008) dKDM2 couples histone H2A ubiquitylation to histone H3 
demethylation during Polycomb group silencing. Genes Dev 22:2799-2810 
Lan F, Bayliss PE, Rinn JL, Whetstine JR, Wang JK, Chen S, Iwase S, Alpatov R, 
Issaeva I, Canaani E, Roberts TM, Chang HY, Shi Y (2007) A histone H3 lysine 
27 demethylase regulates animal posterior development. Nature 449:689-694 
Landeira D, Fisher AG (2011) Inactive yet indispensable: the tale of Jarid2. Trends Cell 
Biol 21:74-80 
Laumonnier F, Holbert S, Ronce N, Faravelli F, Lenzner S, Schwartz CE, Lespinasse J, 
Van Esch H, Lacombe D, Goizet C, Phan-Dinh Tuy F, van Bokhoven H, Fryns 
JP, Chelly J, Ropers HH, Moraine C, Hamel BC, Briault S (2005) Mutations in 
PHF8 are associated with X linked mental retardation and cleft lip/cleft palate. J 
Med Genet 42:780-786 
Lederer D, Grisart B, Digilio MC, Benoit V, Crespin M, Ghariani SC, Maystadt I, 
Dallapiccola B, Verellen-Dumoulin C (2012) Deletion of KDM6A, a histone 
demethylase interacting with MLL2, in three patients with Kabuki syndrome. 
Am J Hum Genet 90:119-124 
Lee MG, Norman J, Shilatifard A, Shiekhattar R (2007a) Physical and functional 
association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-
like protein. Cell 128:877-887 
Lee MG, Villa R, Trojer P, Norman J, Yan KP, Reinberg D, Di Croce L, Shiekhattar R 
(2007b) Demethylation of H3K27 regulates polycomb recruitment and H2A 
ubiquitination. Science 318:447-450 
Lee N, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y (2009) The H3K4 
demethylase lid associates with and inhibits histone deacetylase Rpd3. Mol Cell 
Biol 29:1401-1410 
Lee S, Lee SK (2010) Crucial roles of histone-modifying enzymes in mediating neural 
cell-type specification. Curr Opin Neurobiol 20:29-36 
Lee SK, Pfaff SL (2001) Transcriptional networks regulating neuronal identity in the 
developing spinal cord. Nat Neurosci 4 Suppl:1183-1191 
Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, Chevalier B, 
Johnstone SE, Cole MF, Isono K, Koseki H, Fuchikami T, Abe K, Murray HL, 
Zucker JP, Yuan B, Bell GW, Herbolsheimer E, Hannett NM, Sun K, Odom DT, 
Otte AP, Volkert TL, Bartel DP, Melton DA, Gifford DK, Jaenisch R, Young 
RA (2006) Control of developmental regulators by Polycomb in human 
embryonic stem cells. Cell 125:301-313 
Li F, Huarte M, Zaratiegui M, Vaughn MW, Shi Y, Martienssen R, Cande WZ (2008) 
Lid2 is required for coordinating H3K4 and H3K9 methylation of 
heterochromatin and euchromatin. Cell 135:272-283 
                                                                                                                                      Fueyo et al. 
22  
Liu W, Tanasa B, Tyurina OV, Zhou TY, Gassmann R, Liu WT, Ohgi KA, Benner C, 
Garcia-Bassets I, Aggarwal AK, Desai A, Dorrestein PC, Glass CK, Rosenfeld 
MG (2010) PHF8 mediates histone H4 lysine 20 demethylation events involved 
in cell cycle progression. Nature 466:508-512 
Loenarz C, Ge W, Coleman ML, Rose NR, Cooper CD, Klose RJ, Ratcliffe PJ, 
Schofield CJ (2010) PHF8, a gene associated with cleft lip/palate and mental 
retardation, encodes for an Nepsilon-dimethyl lysine demethylase. Hum Mol 
Genet 19:217-222 
Lois S, Akizu N, de Xaxars GM, Vazquez I, Martinez-Balbas M, de la Cruz X (2010) 
Characterization of structural variability sheds light on the specificity 
determinants of the interaction between effector domains and histone tails. 
Epigenetics 5:137-148 
Luger K (2003) Structure and dynamic behavior of nucleosomes. Curr Opin Genet Dev 
13:127-135 
Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH, Gunther T, 
Buettner R, Schule R (2005) LSD1 demethylates repressive histone marks to 
promote androgen-receptor-dependent transcription. Nature 437:436-439 
Miller SA, Mohn SE, Weinmann AS (2010) Jmjd3 and UTX play a demethylase-
independent role in chromatin remodeling to regulate T-box family member-
dependent gene expression. Mol Cell 40:594-605 
Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP, Johansen JV, Bak M, 
Tommerup N, Rappsilber J, Helin K (2010) JARID2 regulates binding of the 
Polycomb repressive complex 2 to target genes in ES cells. Nature 464:306-310 
Pasini D, Hansen KH, Christensen J, Agger K, Cloos PA, Helin K (2008) Coordinated 
regulation of transcriptional repression by the RBP2 H3K4 demethylase and 
Polycomb-Repressive Complex 2. Genes Dev 22:1345-1355 
Pattaroni C, Jacob C (2013) Histone methylation in the nervous system: functions and 
dysfunctions. Mol Neurobiol 47:740-756 
Pedersen MT, Helin K (2010) Histone demethylases in development and disease. 
Trends Cell Biol 20:662-671 
Peng JC, Valouev A, Swigut T, Zhang J, Zhao Y, Sidow A, Wysocka J (2009) 
Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene 
occupancy in pluripotent cells. Cell 139:1290-1302 
Pfau R, Tzatsos A, Kampranis SC, Serebrennikova OB, Bear SE, Tsichlis PN (2008) 
Members of a family of JmjC domain-containing oncoproteins immortalize 
embryonic fibroblasts via a JmjC domain-dependent process. Proc Natl Acad 
Sci U S A 105:1907-1912 
Qi HH, Sarkissian M, Hu GQ, Wang Z, Bhattacharjee A, Gordon DB, Gonzales M, Lan 
F, Ongusaha PP, Huarte M, Yaghi NK, Lim H, Garcia BA, Brizuela L, Zhao K, 
Roberts TM, Shi Y (2010) Histone H4K20/H3K9 demethylase PHF8 regulates 
zebrafish brain and craniofacial development. Nature 466:503-507 
Qiu J, Shi G, Jia Y, Li J, Wu M, Dong S, Wong J (2010) The X-linked mental 
retardation gene PHF8 is a histone demethylase involved in neuronal 
differentiation. Cell Res 20:908-918 
Schmitz SU, Albert M, Malatesta M, Morey L, Johansen JV, Bak M, Tommerup N, 
Abarrategui I, Helin K (2011) Jarid1b targets genes regulating development and 
is involved in neural differentiation. EMBO J 30:4586-4600 
Secombe J, Li L, Carlos L, Eisenman RN (2007) The Trithorax group protein Lid is a 
trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. 
Genes Dev 21:537-551 
                                                                                                                                      Fueyo et al. 
23  
Shahhoseini M, Taghizadeh Z, Hatami M, Baharvand H (2013) Retinoic acid dependent 
histone 3 demethylation of the clustered HOX genes during neural 
differentiation of human embryonic stem cells. Biochem Cell Biol 91:116-122 
Shen X, Kim W, Fujiwara Y, Simon MD, Liu Y, Mysliwiec MR, Yuan GC, Lee Y, 
Orkin SH (2009) Jumonji modulates polycomb activity and self-renewal versus 
differentiation of stem cells. Cell 139:1303-1314 
Sher F, Rossler R, Brouwer N, Balasubramaniyan V, Boddeke E, Copray S (2008) 
Differentiation of neural stem cells into oligodendrocytes: involvement of the 
polycomb group protein Ezh2. Stem Cells 26:2875-2883 
Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA (2004) 
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. 
Cell 119:941-953 
Shin S, Janknecht R (2007) Activation of androgen receptor by histone demethylases 
JMJD2A and JMJD2D. Biochem Biophys Res Commun 359:742-746 
Shpargel KB, Sengoku T, Yokoyama S, Magnuson T (2012) UTX and UTY 
demonstrate histone demethylase-independent function in mouse embryonic 
development. PLoS Genet 8:e1002964 
Sola S, Xavier JM, Santos DM, Aranha MM, Morgado AL, Jepsen K, Rodrigues CM 
(2011) p53 interaction with JMJD3 results in its nuclear distribution during 
mouse neural stem cell differentiation. PLoS One 6:e18421 
Song MR, Ghosh A (2004) FGF2-induced chromatin remodeling regulates CNTF-
mediated gene expression and astrocyte differentiation. Nat Neurosci 7:229-235 
Stender JD, Pascual G, Liu W, Kaikkonen MU, Do K, Spann NJ, Boutros M, Perrimon 
N, Rosenfeld MG, Glass CK (2012) Control of proinflammatory gene programs 
by regulated trimethylation and demethylation of histone H4K20. Mol Cell 
48:28-38 
Strobl-Mazzulla PH, Sauka-Spengler T, Bronner-Fraser M (2010) Histone demethylase 
JmjD2A regulates neural crest specification. Dev Cell 19:460-468 
Suzuki T, Minehata K, Akagi K, Jenkins NA, Copeland NG (2006) Tumor suppressor 
gene identification using retroviral insertional mutagenesis in Blm-deficient 
mice. EMBO J 25:3422-3431 
Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F, Li J, Rao A, Shi Y 
(2007) The histone H3K4 demethylase SMCX links REST target genes to X-
linked mental retardation. Nature 447:601-605 
Tang Y, Li T, Li J, Yang J, Liu H, Zhang XJ, Le W (2014) Jmjd3 is essential for the 
epigenetic modulation of microglia phenotypes in the immune pathogenesis of 
Parkinson's disease. Cell Death Differ 21:369-380 
Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ (2007) How chromatin-binding 
modules interpret histone modifications: lessons from professional pocket 
pickers. Nat Struct Mol Biol 14:1025-1040 
Trojer P, Zhang J, Yonezawa M, Schmidt A, Zheng H, Jenuwein T, Reinberg D (2009) 
Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone 
Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing 
JMJD2/KDM4 Proteins. J Biol Chem 284:8395-8405 
Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, 
Zhang Y (2006) Histone demethylation by a family of JmjC domain-containing 
proteins. Nature 439:811-816 
Tsukada Y, Ishitani T, Nakayama KI (2010) KDM7 is a dual demethylase for histone 
H3 Lys 9 and Lys 27 and functions in brain development. Genes Dev 24:432-
437 
                                                                                                                                      Fueyo et al. 
24  
Tsurubuchi T, Ichi S, Shim KW, Norkett W, Allender E, Mania-Farnell B, Tomita T, 
McLone DG, Ginsberg N, Mayanil CS (2013) Amniotic fluid and serum 
biomarkers from women with neural tube defect-affected pregnancies: a case 
study for myelomeningocele and anencephaly: clinical article. J Neurosurg 
Pediatr 12:380-389 
Tzschach A, Lenzner S, Moser B, Reinhardt R, Chelly J, Fryns JP, Kleefstra T, 
Raynaud M, Turner G, Ropers HH, Kuss A, Jensen LR (2006) Novel 
JARID1C/SMCX mutations in patients with X-linked mental retardation. Hum 
Mutat 27:389 
Wang J, Park JW, Drissi H, Wang X, Xu RH (2013) Epigenetic Regulation of miR-302 
by JMJD1C Inhibits Neural Differentiation of Human Embryonic Stem Cells. J 
Biol Chem 289:2384-2395  
Wen H, Li J, Song T, Lu M, Kan PY, Lee MG, Sha B, Shi X (2010) Recognition of 
histone H3K4 trimethylation by the plant homeodomain of PHF2 modulates 
histone demethylation. J Biol Chem 285:9322-9326 
Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, Spooner E, Li E, 
Zhang G, Colaiacovo M, Shi Y (2006) Reversal of histone lysine trimethylation 
by the JMJD2 family of histone demethylases. Cell 125:467-481 
Yamane K, Tateishi K, Klose RJ, Fang J, Fabrizio LA, Erdjument-Bromage H, Taylor-
Papadimitriou J, Tempst P, Zhang Y (2007) PLU-1 is an H3K4 demethylase 
involved in transcriptional repression and breast cancer cell proliferation. Mol 
Cell 25:801-812 
Yamane K, Toumazou C, Tsukada Y, Erdjument-Bromage H, Tempst P, Wong J, 
Zhang Y (2006) JHDM2A, a JmjC-containing H3K9 demethylase, facilitates 
transcription activation by androgen receptor. Cell 125:483-495 
Yu L, Wang Y, Huang S, Wang J, Deng Z, Zhang Q, Wu W, Zhang X, Liu Z, Gong W, 






   Pax6, Otx2
   
   Pax6, Otx2
   
Jarid1b
PRC2




   
         
            
      
   
   
   
   
   
   
   
   
Figure 1
   
H3K27me3





   RARE Jmjd3
SMRT
   Dlx5
   
   




   RARE Jmjd3
   Dlx5










Smrt KO mice embryos 
Neurog2   
      
   
   
   
JMJD3
Neurog2
RNAPII       
   5SerP
   
      
Neurog2
RNAPII
   
   
   






            








   
H3K27me3
phosphorylation in serine 22SerP
























FAMILY HDM OTHER NAMES HISTONE SUBSTRATE REFERENCES RELATED HUMAN HMT
KDM1A KDM1, KIAA0601, LSD1, AOF2 H3K4me2/me1, H3K9me2/me1 Shi et al. 2004, Metzger et al. 2005
KDM1B LSD2, AOF1, C6orf193 H3K4me2/me1, H3K9me2/me1 Ciccone et al. 2009
KDM2A JHDM1A, KIAA1004, CXXC8, FBL7, FBXL11 H3K36me2/me1 Tsukada et al. 2006
KDM2B JHDM1B, CXXC2, FBL10, FBXL10, PCCX2 H3K4me3, H3K36me2 Frescas et al. 2007, He et al. 2008
KDM3A JHDM2A, JMJD1, JMJD1A, KIAA0742, TSGA H3K9me2/me1 Yamane et al. 2006
KDM3B JHDM2B, JMJD1B, KIAA1082, C5orf7 H3K9me2/me1 Kim et al. 2012
JMJD1C JHDM2C, KIAA1380, TRIP8 H3K9me2/me1 Kim et al. 2010
KDM4A JHDM3A, JMJD2A, KIAA0677 H3K9me3/me2, H3K36me3/me2, H1.4K26me3 Whetstine et al. 2006, Klose et al. 2006, Trojer et al. 2009
KDM4B JHDM3B, JMJD2B, KIAA0876 H3K9me3/me2, H3K36me3/me2, H1.4K26me3 Whetstine et al. 2006, Fodor et al. 2006, Trojer et al. 2009
KDM4C JHDM3C, JMJD2C, KIAA0780, GASC1 H3K9me3/me2, H3K36me3/me2, H1.4K26me3 Whetstine et al. 2006, Cloos et al. 2006, Trojer et al. 2009
KDM4D JHDM3D, JMJD2D, FLJ10251 H3K9me3/me2, H1.4K26me3/me2 Whetstine et al. 2006, Trojer et al. 2009
KDM5A JARID1A, RBP2 H3K4me3/me2 Christensen et al. 2007, Klose et al.  2007
KDM5B JARID1B, PLU1 H3K4me3/me2 Christensen et al. 2007
KDM5C JARID1C, SMCX H3K4me3/me2 Christensen et al. 2007, Iw ase et al. 2007
KDM5D JARID1D, SMCY H3K4me3/me2 Lee et al. 2007a
KDM6A UTX H3K27me3/me2 Agger et al. 2007, Lan et. Al 2007
KDM6B JMJD3, KIAA0346 H3K27me3/me2 Agger et al. 2007, Lan et. Al 2007
UTY
KDM7A JHDM1D, KIAA1718, KDM7 H3K9me2/me1, H3K27me2/me1 Tsukada et al. 2010, Horton et al. 2010, Huang et al. 2010b
PHF8 JHDM1F, KIAA1111, ZNF422 H3K9me2/me1, H4K20me1 Loenarz et al. 2010, Liu et al. 2010, Qi et al. 2010 
PHF2 JHDM1E, KIAA0662 H3K9me2/me1, H4K20me3 Wen et al. 2010, Baba et al. 2011, Stender et al. 2012 
* after GlcNAcylation
Table 1. Human histone demethylases
LSD
H3K4me2/me1: SETD1A-B, KMT2A-D, KMT2E*; 
H3K4me1: ASH1L, SETD7; H3K9me2: SUV39H1-
2; H3K9me2/me1: SETDB1, EHMT1-2, PRDM2.
JMJC
H3K4me3: KMT2A-D, SETD1A-B, SMYD3, ASH1L, 
PRMD9; H3K36me2: SMYD2; H3K36me2/me1: 
SETD2, SETMAR, NSD1-3, ASH1L.
H3K9me2: SUV39H1-2; H3K9me2/me1: SETDB1, 
EHMT1-2, PRDM2.
H3K9me3: SETD2; H3K9me3/me2: SUV39H1-2, 
SETDB1, PRDM2; H3K9me2: EHMT1-2; 
H3K36me3/me2: SETD2, NSD1-3, ASH1L, SMYD2; 
H3K36me2: SETMAR; H1.4K26me3/me2: EZH2, 
EHMT1-2.
H3K4me3: ASH1L, PRDM9; H3K4me3/me2: 
KMT2A-D, SETD1A-B, SMYD3.
H3K27me3/me2: EZH1-2.
H3K9me2: SUV39H1-2; H3K9me2/me1: SETDB1, 
EHMT1-2, PRDM2; H3K27me2/me1: EZH1-2; 
H4K20me3: SMYD5, SUV420H2; H4K20me1: 
SETD8.
Table2. JMJC demethylases and their role in neural development and disease 
HDM Function in Neural Development Associated pathologies References 
KDM2B Embryonic neural tube development and neurulation in mice.   Fukuda et al. 2011 
JMJD1C Inhibition of  neural differentiation in hESC.   Wang et al. 2014 
KDM4A Neural crest specification in chick embryo.   Strobl-Mazzulla et al. 2010  
KDM4C   Autism spectrum disorders. Kantojarvi et al. 2010 
KDM5B Repression of stem cell genes to allow ESC differentiation into neurons.   Schmitz et al. 2011, Albert et al. 2013 
KDM5C 
Repression of neuronal genes in non-neuronal cells. Neuronal survival and 
dendritic development. 
X-linked mental retardation, autism 
spectrum disorders, epilepsy. 
Jensen et al. 2005, Tahiliani et al. 2007, 
Iwase et al. 2007, Adegbola et al. 2008 
KDM6A Induction of neural differentiation in hESC. Kabuki syndrome. Lederer et al. 2012, Shahhoseini et al. 2013 
KDM6B 
Forebrain development antagonized by SMRT in isolated cortical progenitors. 
Neuronal differentiation in P19 cells. Neural commitment of ESC. BMP-induced 
dorsal interneurons generation in chick embryo neural tube. TGFβ-induced 
neuronal differentiation in mNSC. 
  
Jepsen et al. 2007,  Burgold et al. 2008, Dai 




KDM7A Neural differentiation in mESCs. Neural induction on early chick embryos.    Huang et al. 2010a, Huang et al. 2010b 
PHF8 
Tectum development and neural survival in zebrafish embryos. Interaction with 
ZNF711 and regulation of JARID1C. Regulation of cytoskeleton-related genes 
neccesary for proper neurite formation.  
X linked mental retardation, cleft 
lip/palate. 
Laumonnier et al. 2005,  Qi et al. 2010,  
Tsukada et al. 2010, Kleine-Kohlbrecher et 
al. 2010, Asensio-Juan et al. 2012 
